|
|
| MRD / Regn No. |
: 20260000612 |
Date |
: 02/07/2026 |
| Patient Name |
: Jiten Nandi |
Age & Gender |
: 51 Yrs. / Male |
| Contact No. |
: 7384736324 |
UHID |
: |
| Ht / Wt / BMI |
: 159 / 66 / 26.11 |
BP S / BP D |
: 110 / 70 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (02/Jul/2021) | F0S2 MASLD (02/Jul/2026) | |
|
Subjective |
: |
DM FOR 5 YEARS,DYSLIPIDEMIA
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,CDR ON OCT > 0.3,S2F0 NAFLD |
|
Plan |
: |
START GLP1RA SGLT2I,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
ESR: 7 mm/hour | FASTING PLASMA GLUCOSE (FPG): 162 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.8 % | POST PRANDIAL GLUCOSE (2HPP): 349 mg/dL | HEMOGLOBIN: 13.5 g/dL | MCH: 29 pg | MCHC: 34 gm % | MCV: 86 fl | PCV: 40 % | PLATELETS: 123 thou cells/ ul | RBC COUNT: 4.61 million/ul | TOTAL COUNT WBC: 6.81 Cells/cmm | TSH : 2.540 mIU/L | UREA: 23 mg/dL | CREATININE: 0.85 mg/dL | 24 H URINARY CALCIUM: 4.2 mg/24 hours | HDL HIGH DENSITY LIPOPROTEIN: 38 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 66 mg/dL | TGL TRIGLYCERIDE: 263 mg/dL | TOTAL CHO/HDL RATIO: 3.5 | TOTAL CHOLESTEROL: 132 mg/dl | VLDL: 53 mg/dl | A\G RATIO: 1.94 g/dl | ALBUMIN (SERUM): 4.84 g/dL | ALKALINE PHOSPHOTASE: 69 IU/L | DIRECT BILIRUBIN: 0.76 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 33 U/L | GLOBULIN: 2.50 g/dl | INDIRECT BILIRUBIN: 1.74 | SGOT (AST): 40 U/L | SGPT (ALT): 67 IU/L | TOTAL BILIRUBIN: 2.50 mg/dL | TOTAL PROTEIN: 7.34 g/dl | BICARBONATE: 25 meq/L | CHLORIDE: 100 meq/L | POTASSIUM: 4.0 meQ/L | SODIUM: 137 meq/L | CALCIUM: 9.4 mg/DL | MICROALBUMIN CREATININE RATIO: 2.96 mcg/mg | CUP DISC RATIO L: 0.18 | CUP DISK RATIO R: 0.20 | ABI LEFT: 1.07 | ABI RIGHT: 1.05 | E / E PRIME: 11 | EJECTION FRACTION: 60 % | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | FIB4: 2.03 | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | FIB4: 2.03 | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | FIB4: 2.03 | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 101.11 mL/min/1.73m2 | FIB4: 2.03 | FIB4: 2.03 | LIVER CAP: 271 dB/M | LIVER ELASTICITY: 4.8 kPA | LIVER METAVIR SCORE: S2 | LIVER STEATOSIS SCORE: F0 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION SEMAGLUTIDE
SEMALIX 0.25 MG
Medicine For DIABETES OBESITY MASLD CAD |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING OR EYE DISTURBANCE | |
|
2 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
3 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 01/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP SMBG |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |